Lauren Averett Byers, MD, MS
机构: MD Anderson Cancer Center
每年引用次数
引用次数
引用: 40,634
H-指数: 75
I10-指数 : 171
出版物: 489
Combined inhibition of AXL and ATR enhances cell death and immune response in small cell lung cancer
Kavya Ramkumar , Azusa Tanimoto , C Allison Stewart , Qi Wang
Cancer Research 82 ( 12_Supplement) 2602 -2602
2022
Abstract A059: Tackling the tumor microenvironment with CD38 blockade to enhance cancer immunotherapy
Limo Chen , Lixia Diao , Xiaohui Yi , Bertha Leticia Rodriguez
Cancer Immunology Research 7 ( 2_Supplement) A059 -A059
2019
Exploiting the G2-M cell cycle checkpoint dependency in small cell lung cancer (SCLC) using pharmacological inhibitors of CHK1 and WEE1
Triparna Sen , Pan Tong , Catherine Allison Stewart , Sandra Cristea
MOLECULAR CANCER RESEARCH 14
2016
Abstract B36: The role of the microRNA-200 family in the regulation of tumor cell signaling and metastasis in lung cancer
Jonathon D Roybal , David H Peng , Christin Ungewiss , Pijus K Mandal
Cancer Research 75 ( 1_Supplement) B36 -B36
2015
Growth and metastasis of lung adenocarcinoma is potentiated by BMP4-mediated immunosuppression
Xiaohui Yi Limo Chen , Sangeeta Goswami , Young-Ho Ahn , Jonathon D Roybal
The multitargeted kinase inhibitor dasatinib induces DNA damage, Hippo pathway engagement and senescence in lung cancer cell lines that possess kinase-inactivating BRAF mutations
Banibrata Sen , Shaohua Peng , Tuhina Mazumdar , Lauren A Byers
Cancer Research 74 ( 19_Supplement) 3707 -3707
2014
Co-occurring Genomic Alterations Define Major Subsets of KRAS-Mutant Lung Adenocarcinoma with Distinct Biology, Immune Profiles, and Therapeutic Vulnerabilities
Ferdinandos Skoulidis , Lauren A Byers , Lixia Diao , Vassiliki A Papadimitrakopoulou
Cancer Discovery 5 ( 8) 860 -877
637
2015
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
Erminia Massarelli , Vincent K Lam , Edwin R Parra , Jaime Rodriguez-Canales
Journal for ImmunoTherapy of Cancer 7 ( 1) 351
9
2019
Abstract A084: High OX-40 expression on the tumor immune infiltrate is a prognostic factor of better survival in non-small cell lung cancer
Erminia Massarelli , Edwin R Parra , Jaime Rogriguez-Canales , Carmen Behrens
Cancer immunology research 4
1
2016
NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma
Faye M Johnson , Vaishnavi Sambandam , Li Shen , Ming Zhang
Cancer Research 76 ( 14_Supplement) 393 -393
1
2016
Integrative drug sensitivity analysis of PI3K/mTOR pathway inhibitors in Head and Neck Squamous Cell Carcinoma (HNSCC)
Vaishnavi Sambandam , Li Shen , Ming Zhang , Rishi Saigal
Cancer Research 75 ( 15_Supplement) 417 -417
2015
Combined inhibition of AXL and ATR enhances replication stress, cell death and immune response in small cell lung cancer
Kavya Ramkumar , C Allison Stewart , Azusa Tanimoto , Qi Wang
Cancer Research 83 ( 7_Supplement) 6206 -6206
1
2023
Comprehensive metabolic profiling and vulnerabilities to metabolic inhibitors among small cell lung cancer subtypes
Kasey R Cargill , Carl M Gay , Robert J Cardnell , You-Hong Fan
Cancer Research 80 ( 16_Supplement) 232 -232
1
2020
Activity of HER2-and TROP2-antibody drug conjugates (ADCs) in small cell lung cancer (SCLC) models with SLFN11 as a predictive biomarker
Bingnan Zhang , Ali Ibrahim , C Allison Stewart , Lixia Diao
Cancer Research 84 ( 6_Supplement) 6392 -6392
2024
Advancing personalized therapies for small cell lung cancer: Exploring HER2-targeting antibody-drug conjugates (ADCs) and SLFN11 biomarker insights
Ali H Ibrahim , Bingnan Zhang , C Allison Stewart , Alejandra Serrano
MOLECULAR CANCER THERAPEUTICS 22 ( 12)
2023
Abstract LB_A22: Advancing personalized therapies for small cell lung cancer: Exploring HER2-targeting antibody-drug conjugates (ADCs) and SLFN11 biomarker insights
Ali H Ibrahim , Bingnan Zhang , C Allison Stewart , Alejandra Serrano
NaN ( 12_Supplement) LB_A22 -LB_A22
2023
Defining the transcriptional complexity of persister cell populations in relapsed small cell lung cancer patient biopsies
C Allison Stewart , Yuanxin Xi , Runsheng Wang , Michael M Frumovitz
Cancer Research 82 ( 12_Supplement) 1598 -1598
2022
The impact of targeting TRAF2 and NCK-interacting protein kinase (TNIK) on anti-tumor effect in small cell lung cancer
Azusa Tanimoto , Ben Morris , Kavya Ramkumar , Robert Cardnell
2022
Characterization of lurbinectedin as a single agent and in combinations with DNA damage response inhibitor for the treatment and bio-marker discovery of SCLC
Kiran Kundu , Robert J Cardnell , Li Shen , C Allison Stewart
Cancer Research 81 ( 13_Supplement) 1022 -1022
2021
Targeting MYC-enhanced glycolysis in small cell lung cancer
Kasey R Cargill , C Allison Stewart , Elizabeth M Park , Robert J Cardnell
Cancer Research 81 ( 13_Supplement) 2335 -2335
2021